4-Hydroxy-2,2,6,6-tetramethylpiperidine
데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
2403-88-5CC1(C)CC(O)CC(C)(C)N1VDVUCLWJZJHFAV-UHFFFAOYSA-NRN given refers to parent cpd
2403-88-5DTXSID3029655CHEMBL117625안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 2.5% (5 of 201) of reports.
Danger
H302 (65.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P260, P261, P264, P264+P265, P270, P272, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P333+P317, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 201 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
Status: Active Update: 22-07-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/14709
2,2,6,6-Tetramethyl-4-piperidinol: Does not have an individual approval but may be used under an appropriate group standard
Acute Tox. 4 (65.7%)
Acute toxicity (Oral) - Category 4
용도2,2,6,6-tetramethyl-4-piperidinol has been used to study the irradiation of Camptothecin (CPT) in aerated dimethylsulfoxide (DMSO) solution that leads to formation of singlet oxygen.
불러오는 중…
white to slightly beige crystalline powder